Specific cellular and humoral immune response in Balb/c mice immunised with an expression genomic library of Trypanosoma cruzi

Vaccine

Volumn 16, Issue 6, 1998, Pages 608-612

  Alberti, Esteban ^a   Acosta, Armando ^b   Sarmiento, Maria E ^b   Hidalgo, Carlos ^b   Vidal, Teresita ^b   Fachado, Alberto ^a   Fonte, Luis ^a   Izquierdo, Luis ^b   Infante, Juan F ^b   Finlay, Carlos M ^a   Sierra, Gustavo ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b FINLAY INSTITUTE   (Cuba)

Author keywords

Genomic expression library; Immunisation; T. cruzi

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; PLASMID DNA; TRYPANOSOMA CRUZI VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CHAGAS DISEASE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE CONSTRUCT; GENE LIBRARY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE; INTRAMUSCULAR DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TRYPANOSOMA CRUZI;

ANIMALS; ANTIBODY FORMATION; ANTIBODY SPECIFICITY; DNA, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOME, PROTOZOAN; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTOZOAN VACCINES; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 0032054004     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00228-4     Document Type: Article

References (24)

1. 1 Jazin, E.E., Botempi, E.J., Sanchez, D.O., Aslund, L., Heriksson, J. and Frasch, A.C.C. et al. Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family. Parasitology 1995, 110, 61-69.
2. 2 Pérez Duque, G.A., Escalanleg, R., Sausa-Junior, A.H. and Habr, G.A. Carlos Chagas and Chagas disease. Gene 1995, 49, 179-188.
3. 3 Asin, S.N. and Giojolo, L.C. Type of rectal contents and infectivity of domiciliary population of Triatoma infestans (Hemiptera: Reduvdidae) in Argentina. J. Med. Entomol. 1995, 32, 399-401.
4. 4 Vergara, V., Lorca, M., Engestrom, A. and Veloso, C. Serum antibodies against synthetic peptides from Trypanosoma cruzi antigens in Chagas' disease patients. Inmunología 1995, 14, 1-4.
5. 5 Schrevel, J., Meelriaux, V., Senan, V., Frappier, F., Santus, R. and Grillier, P. New trends in chemotherapy on human and animal blood parasites. Parasitol. Res. 1996, 82, 283-284.
6. 6 Ouaissi, M.A., Taibi, J., Cornette, J., Velge, P., Marty, B. and Loyens, M. et al. Characterization of major surface and excretory secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigens. Parasitology 1990, 100, 115-124.
7. 7 Sepulveda, B.S. and Cassels, B.K. Plant metabolites actives against Trypanosoma cruzi. Planta Med. 1996, 62, 98-105.
8. 8 Rodríguez, J.B. and Gros, E.E. Recent development in the control of Trypanosoma cruzi, the causative agent of Chagas' disease. Curr. Med. Chem. 1995, 2, 723-742.
9. 9 Basambrio, M.A. Trypanosoma cruzi: partial prevention of the natural infection of guinea pig with a killed parasite vaccine. Exp. Parasitol. 1990, 71, 1-8.
10. 10 Milei, J., Storino, R.A., Beigelman, R., Grana, P. and Basombrio, M.A. Morphometry of skeletal muscle involvement in mice infected or preimmunized with live attenuated Trypanosoma cruzi. Medicina B. Aires 1991, 51, 529-532.
11. 11 Vogel. R.F. and Sarvel, N. Nucleic acid vaccines. Clin. Microbiol. Rev. 8, 1995, 406-410.
12. 12 Ulmer, J.B., Donnelly, J.J., Parker, S.E., Rhodes, G.H., Felgener, P.L. and Dwark, U.J. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1749.
13. 13 Davis, H.L., Michel, M.L., Mancini, M., Schleef, M. and Whalem, R.G. Direct gene transfer in skeletal muscle: plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 1994, 12, 1503-1508.
14. 14 Hoffman, S.L., Sedejah, M. and Hedstrom, R.C. Protection against malaria by immunization with Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 1994, 12, 1529-1533.
15. 15 Xu, D. and Liew, F. Genetic vaccination against Leishmaniasis. Vaccine 1994, 12, 1534-1536.
16. 16 Barry, A.M., Lai, W.C. and Johnston, A.S. Protection against mycoplasma infection using expression library immunization. Nature 1995, 377, 632-635.
17. 17 Moncayo, A. Chagas' Disease: epidemiology and prospects for interruption of transmission in the Americas. World Hlth Stat. Q. 1992, 45, 276-279.
18. 18 Camargo, E.P. Growth and differentation in Trypanosoma cruzi. 1. Origin of metacyclic trypanosoma in liquid media. Rev. Inst. Med. Trop. Sao Paulo 1964, 6, 93-100.
19. 19 Lowry, D.H., Rosebraugh, N.J., Farr, A.L. and Randall, R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193, 265-275.
20. 20 Sambrook, J., Frisch, E.F. and Maniatis, T. Molecular Cloning: A Laboratory Manual (2nd edn). Laboratory Press, Cold Spring Harbor, NY, 1989
21. 21 Camargo, M.E. Flurescent antibody test for serodiagnosis. Technical modification employing preserved cultured forms of T. cruzi in slide test. Rev. Inst. Med. Trop. de Sao Paulo 1966. 8, 227-234.
22. 22 Peralta, J.M., Texeira, M.M.G., Shriffler, W.G., Pereira, J.B., Burns, J.M. and Sleath, P.R. et al. Serodiagnosis of Chagas' disease by enzyme-linked immunosorbent assay using two synthetic peptides as antigen. J. Clin. Microb. 1994, 32, 971-974.
23. 23 Van Voorhis, W.C. and Eisen, H. A surface antigen of Trypanosoma cruzi that mimics mammalian nervous tissue. J. Exp. Med. 1989, 169, 641-652.
24. 24 Frederick, R.V. Nava, Sarver. Nucleic acid vaccines. Clin. Microbiol. Rev. 1995, 8, 406-410.